APT Medical Inc. (SHA:688617)

Market Cap	36.14B +2.2%
Revenue (ttm)	2.58B +25.1%
Net Income	820.64M +21.9%
EPS	5.80 +21.8%
Shares Out	140.63M
PE Ratio	44.31
Forward PE	35.02
Dividend	1.00 (0.39%)
Ex-Dividend Date	Jun 19, 2025

Volume	972,448
Average Volume	1,189,353
Open	255.94
Previous Close	256.10
Day's Range	253.20 - 260.00
52-Week Range	219.48 - 337.20
Beta	-0.26
RSI	60.03
Earnings Date	Mar 25, 2026

About APT Medical

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addit...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 3,118
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2025, APT Medical's revenue was 2.58 billion, an increase of 25.08% compared to the previous year's 2.07 billion. Earnings were 820.64 million, an increase of 21.91%.